Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China · Delayed Price · Currency is CNY 62.38
+2.33 (3.88%)
Jul 31, 2026, 3:04 PM CST
SHE:002653 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 5,060 | 4,388 | 3,721 | 3,355 | 3,015 | 2,773 |
Revenue Growth | 31.04% | 17.91% | 10.92% | 11.27% | 8.72% | -16.71% |
Gross Profit Gross Profit Growth | 3,767 | 3,121 | 2,660 | 2,384 | 2,090 | 1,826 |
Operating Income Operating Income Growth | 686.68 | 199.62 | 262.03 | 331.58 | 141.57 | 37.6 |
Net Income Net Income Growth | 767.58 | 259.58 | 395.46 | 295.11 | 277.07 | 345.06 |
Earnings Per Share EPS Growth | 0.69 | 0.23 | 0.35 | 0.27 | 0.26 | 0.32 |
EPS Growth | 123.02% | -34.29% | 29.63% | 3.85% | -18.75% | -45.76% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Parent Company Parent Company Growth | 4,397 |
Tibet Haize Tibet Haize Growth | 534.79 |
Tibet Pharmaceuticals Merger Tibet Pharmaceuticals Merger Growth | 2,553 |
Liaoning Hisun Liaoning Hisun Growth | 548.14 |
Intersegment Effect Intersegment Effect Growth | -4,497 |
Shenyang Hisun Shenyang Hisun Growth | 287.23 |
Sichuan Hisun Corporation Merger Sichuan Hisun Corporation Merger Growth | 530.58 |
Total Total Growth | 4,354 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,940 | 1,386 | 1,206 | 1,329 | 775.39 | 575.11 |
Total Debt Total Debt Growth | 2,237 | 1,980 | 1,910 | 1,807 | 2,111 | 1,249 |
Net Cash (Debt) Net Cash Growth | -296.6 | -593.2 | -704.22 | -477.74 | -1,336 | -674.16 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.27 | -0.53 | -0.62 | -0.44 | -1.25 | -0.63 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,116 | 786 | 442.05 | 449.58 | 94.55 | 35.8 |
Capital Expenditures CapEx Growth | -306.37 | -331.98 | -440.65 | -391.01 | -700.17 | -702.94 |
Free Cash Flow Free Cash Flow Growth | 809.8 | 454.03 | 1.39 | 58.57 | -605.62 | -667.14 |
Free Cash Flow Growth | - | 32537.74% | -97.63% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 74.46% | 71.14% | 71.47% | 71.05% | 69.31% | 65.86% |
Operating Margin | 13.57% | 4.55% | 7.04% | 9.88% | 4.70% | 1.36% |
Pretax Margin | 15.97% | 6.24% | 12.44% | 9.02% | 12.16% | 18.42% |
Profit Margin | 15.17% | 5.92% | 10.63% | 8.80% | 9.19% | 12.44% |
FCF Margin | 16.00% | 10.35% | 0.04% | 1.75% | -20.09% | -24.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.267 | 0.267 | 0.415 | 0.200 | - | 0.185 |
Dividend Per Share Growth | -35.66% | -35.66% | 107.50% | - | - | -50.22% |
Dividend Yield | 0.43% | 0.52% | 1.26% | 0.89% | - | 0.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 90.58 | 219.31 | 93.27 | 86.56 | 85.52 | 63.02 |
Forward PE | 78.96 | 91.92 | 58.20 | 62.99 | 69.53 | 62.77 |
P/FCF Ratio | 85.45 | 125.38 | 26513.18 | 436.15 | - | - |
PS Ratio | 13.68 | 12.97 | 9.91 | 7.61 | 7.86 | 7.84 |